BMTBiomaterials TranslationalTBA2096-112XBiomaterials Translational10.3877/cma.j.issn.2096-112X.2021.01.001EditorialUsing biomaterials research to address the challenges raised by the COVID-19 pandemichttps://artdesignp.com/journal/BMT/2/1/10.3877/cma.j.issn.2096-112X.2021.01.001WangQian2021212021-03-28

1. Ge, T.; Cheng, S. Physicochemical properties of respiratory droplets and their role in COVID-19 pandemics: a critical review. Biomater Transl. 2021, 2, 10-18. 2. Seong, D.; Kingsak, M.; Lin, Y.; Wang, Q.; Hoque, S. Fate and transport of enveloped viruses in indoor built spaces – through understanding vaccinia virus and surface interactions. Biomater Transl. 2021, 2, 50-60. 3. Jatoi, I.; Fan, J. A biomaterials viewpoint for the 2020 SARS-CoV-2 vaccine development. Biomater Transl. 2021, 2, 30-42. 4. Rattanapisit, K.; Yusakul, G.; Shanmugaraj, B.; Kittirotruji, K.; Suwatsrisakul, P.; Prompetchara, E.; Taychakhoonavud, S.; Phoolcharoen, W. Plant-produced recombinant SARS-CoV-2 receptor-binding domain; an economical, scalable biomaterial source for COVID-19 diagnosis. Biomater Transl. 2021, 2, 43-49. 5. Buranasudja, V.; Somwangthanaroj, A.; Likitlersuang, S.; Boonyatee, T.; Isarankura-Na-Ayudhya, C.; Luckanagul, J. A. Development of personal protective equipment for the COVID-19 pandemic in Thailand and technical aspects of testing gown materials. Biomater Transl. 2021, 2, 3-9. 6. Wang, Y.; Chu, X.; Wang, B. Recombinant adenoassociated virus-based gene therapy combined with tissue engineering for musculoskeletal regenerative medicine. Biomater Transl. 2021, 2, 19-29.